Spine Fusion clinical trials at University of California Health
2 research studies open to eligible people
Ketamine on Intraoperative Motor Evoked Potentials
open to eligible people ages 18-100
The goal of this clinical trial is to learn about the effect of ketamine on intraoperative motor evoked potentials in adult patients undergoing thoracolumbar spinal fusions. Participants will undergo a standard anesthetic. In addition to the standard anesthetic, the patients will be administered increasing doses of ketamine with motor-evoked potentials being measured at each dose, to assess any impacts.
at UCSF
Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)
open to eligible people ages 10-21
The purpose of this collaborative CTSA application is to develop an innovative perioperative precision analgesia platform (PPAP) to improve analgesia and reduce serious immediate and long-term adverse outcomes of perioperative opioids in children undergoing painful surgery.
at UCSF
Our lead scientists for Spine Fusion research studies include Anshuman Sharma Marc Buren, MD.
Last updated: